1. FO022BARDOXOLONE METHYL PREVENTS EGFR DECLINE IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 4 AND TYPE 2 DIABETES - POST-HOC ANALYSES FROM BEACON. (18th May 2018) Authors: Wanner, Christoph; Bakris, George; Block, Geoffrey; Chin, Melanie; Goldsberry, Angie; Inker, Lesley; Meyer, Colin; O'Grady, Megan; Pergola, Pablo; Warnock, David; Chertow, Glenn Journal: Nephrology dialysis transplantation Issue: Volume 33(2018)Supplement 1 Page Start: i10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FP110A PHASE 2 TRIAL OF THE SAFETY AND EFFICACY OF BARDOXOLONE METHYL IN PATIENTS WITH RARE CHRONIC KIDNEY DISEASES. (18th May 2018) Authors: Pergola, Pablo; Appel, Gerald; Block, Geoffrey; Chin, Melanie; Goldsberry, Angie; Inker, Lesley; Jarad, George; Meyer, Colin; Rastogi, Anjay; Rizk, Dana; Silva, Arnold; Warnock, David Journal: Nephrology dialysis transplantation Issue: Volume 33(2018)Supplement 1 Page Start: i14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FP110A PHASE 2 TRIAL OF THE SAFETY AND EFFICACY OF BARDOXOLONE METHYL IN PATIENTS WITH RARE CHRONIC KIDNEY DISEASES. (18th May 2018) Authors: Pergola, Pablo; Appel, Gerald; Block, Geoffrey; Chin, Melanie; Goldsberry, Angie; Inker, Lesley; Jarad, George; Meyer, Colin; Rastogi, Anjay; Rizk, Dana; Silva, Arnold; Warnock, David Journal: Nephrology dialysis transplantation Issue: Volume 33(2018)Supplement 1 Page Start: i14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FP110A PHASE 2 TRIAL OF THE SAFETY AND EFFICACY OF BARDOXOLONE METHYL IN PATIENTS WITH RARE CHRONIC KIDNEY DISEASES. (18th May 2018) Authors: Pergola, Pablo; Appel, Gerald; Block, Geoffrey; Chin, Melanie; Goldsberry, Angie; Inker, Lesley; Jarad, George; Meyer, Colin; Rastogi, Anjay; Rizk, Dana; Silva, Arnold; Warnock, David Journal: Nephrology dialysis transplantation Issue: Volume 33(2018)Supplement 1 Page Start: i14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FP152EFFECT OF BARDOXOLONE METHYL TREATMENT ON URINARY ALBUMIN IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE - POST-HOC ANALYSIS FROM BEAM AND BEACON. (18th May 2018) Authors: Rossing, Peter; Block, Geoffrey; Chertow, Glenn; Chin, Melanie; Goldsberry, Angie; McCullough, Peter; Meyer, Colin; Packham, David; Spinowitz, Bruce; Sprague, Stuart; Warnock, David; Pergola, Pablo Journal: Nephrology dialysis transplantation Issue: Volume 33(2018)Supplement 1 Page Start: i27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FP152EFFECT OF BARDOXOLONE METHYL TREATMENT ON URINARY ALBUMIN IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE - POST-HOC ANALYSIS FROM BEAM AND BEACON. (18th May 2018) Authors: Rossing, Peter; Block, Geoffrey; Chertow, Glenn; Chin, Melanie; Goldsberry, Angie; McCullough, Peter; Meyer, Colin; Packham, David; Spinowitz, Bruce; Sprague, Stuart; Warnock, David; Pergola, Pablo Journal: Nephrology dialysis transplantation Issue: Volume 33(2018)Supplement 1 Page Start: i27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FP805PROGRESSION OF NEPHROPATHY IN FABRY PATIENTS RECEIVING ENZYME REPLACEMENT THERAPY (ERT); RELATION TO ANTI-DRUG ANTIBODY (ADA) STATUS AND PROTEINURIA. (28th May 2018) Authors: Warnock, David; Alon, Sari; Chertkoff, Raul; Brill-Almon, Einat Journal: Nephrology dialysis transplantation Issue: Volume 33(2018)Supplement 1 Page Start: i634 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗